Skip to content

A prospective study to evaluate the effect of opium poppy iodine oil on post-operative salvage assisted selective salpingography

A prospective study to evaluate the effect of opium poppy iodine oil on post-operative salvage assisted selective salpingography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033809
Enrollment
Unknown
Registered
2020-06-13
Start date
2020-08-08
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tubal infertility

Interventions

experimental group:OSCM
control group:Iodophor

Sponsors

International Peace Maternal and child health care institute affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. 21-38 year old female patients; 2. Patients with infertility lasting for 12 months; 3. The previous hysterosalpingography showed the obstruction of the proximal end of the fallopian tube, the obstruction of the fallopian tube, the obstruction of the fallopian tube, the obstruction of the fallopian tube, the obstruction of the fallopian tube, and the suspected false positive blockage of the fallopian tube (including the undeveloped fallopian tube and the development of the fallopian tube to the distal end); 4. Patients with indications of selective salpingography recanalization; 5. Patients who understand and sign informed consent and operation consent.

Exclusion criteria

Exclusion criteria: 1. Patients with iodine allergy; 2. Patients with hydrosalpinx on both sides; 3. Patients with hyperthyroidism; 4. Patients with vaginitis, active stage of acute or subacute pelvic inflammation, tuberculosis of uterus or fallopian tube; 5. Patients with uterine or cervical hemorrhage; 6. The patients whose menopause has not excluded pregnancy; 7. Patients with severe heart and lung diseases who cannot tolerate surgery; 8. Patients whose body temperature was higher than 37.5 3 days before the recanalization of selective hysterosalpingography; 9. The spouse is a patient with oligospermia, asthenospermia and azoospermia; 10. The investigator judged that the subjects had poor compliance or other complications that were not suitable to participate in the study; 11. Patients who participated in other clinical trials at the same time in the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
ongoing prenancy rate;

Secondary

MeasureTime frame
clinical pregnancy rate;live birth rate;miscarriage rate;ectopic pregnancy rate;VAS;

Countries

China

Contacts

Public ContactZhaoxia Qian

International Peace Maternal and Child Health care institute affiliated to Shanghai Jiaotong University School of Medicine

zhaoxiaqian@163.com+86 18017316027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026